UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Reshaping drug discovery with deep learning and polypharmacology

Cyclica is a Toronto-based biotech that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. We spoke to their Chief Scientific Officer Andreas Windemuth.

Read More

Taking biomarker research to a new level

Ahead of the 6th Digital Pathology and AI Congress: Europe in December, we are revisiting Professor Inti Zlobec’s research, presented at last year’s Congress, which is opening a whole field of digital pathology research. Zlobec’s research applies the latest digital pathology technology to produce high-quality tissue microarrays for biomarker analysis.

Read More

Bridging the gap between pathologist and algorithm

Could AI replace pathologists? As we look forward to the 6th Digital Pathology and AI Congress: Europe on the 5th – 6th December 2019, we look back at Dr Hamid Tizhoosh’s keynote presentation from last year.

Read More

Poster Presentations Release: Microbiome Series Europe

Presented at this year’s Microbiome Series: Europe, these poster presentations are now available to download and share with your colleagues.

Read More

Pixel analysis: the new era of digital pathology

Professor David Snead is leading the implementation of digital pathology for Coventry and Warwickshire Pathology Services and directs one of the five Government funded centres in the UK pioneering AI and image diagnostics integration. His main research interests lie in extending the capability of digital pathology for routine diagnostic use and the advancement and deployment of computer assisted diagnostic algorithms. In this third highlight from the conference we revisit Professor Snead’s presentation to get a clinical perspective on how deep learning and artificial intelligence (AI) are set to play an increasing role in daily practice.

Read More

New sourcing of natural ingredients for cosmeceuticals

The sourcing of natural plant-based compounds is becoming a worldwide bottleneck. The Greenhouse Pharmacy programme of Wageningen University & Research builds new chains between high-tech horticulture and cosmeceutical companies for reliable sourcing of pesticide-free natural plant compounds.

Read More

A regulatory roadmap for the commercialization of microbial products for agriculture

A major paradigm shift in agricultural production is required to meet the demands of a global world population projected to reach 9.7 billion in 2050. We have to increase crop productivity sustainably while preserving biodiversity, natural resources, and grower income in the context of climate change. To optimize sustainable productivity and profitability on farms, grasslands, and forests, scientists and growers must embrace a holistic, systems-level approach and focus on the complexity within phytobiomes.

Read More

Unleashing the power of digital pathology and AI for precision medicine

We’re looking back at the highlights from the Digital Pathology and AI meeting in 2018 as we anticipate this year’s Digital Pathology and AI Congress in December. This second post in our mini-series reviews Marylin Bui’s keynote presentation where she explained how the combination of Digital Pathology and Artificial Intelligence (AI) holds huge potential for patient care.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive